# HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

> **NCT03911388** · PHASE1 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 24 (estimated)

## Conditions studied

- Neoplasms, Brain
- Glioblastoma Multiforme
- Glioblastoma of Cerebellum
- Neoplasms
- Astrocytoma
- Astrocytoma, Cerebellar
- Neuroectodermal Tumors
- Neuroectodermal Tumors, Primitive
- Cerebellar PNET, Childhood
- Cerebellar Neoplasms
- Cerebellar Neoplasms, Primary
- Cerebellar Neoplasm, Malignant
- Cerebellar Neoplasm Malignant Primary
- Neoplasm Metastases
- Neoplasm Malignant
- Neoplasms, Neuroepithelial
- Neoplasms, Germ Cell and Embryonal
- Neoplasms by Histologic Type
- Neoplasms, Glandular and Epithelial
- Neoplasms, Nerve Tissue
- Central Nervous System Neoplasms, Primary
- Central Nervous System Neoplasms, Malignant
- Nervous System Neoplasms
- Neoplasms by Site
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Medulloblastoma Recurrent
- HSV
- Virus
- Pediatric Brain Tumor
- Nervous System Cancer
- Primitive Neuroectodermal Tumor (PNET) of Cerebellum

## Interventions

- **BIOLOGICAL:** G207

## Key facts

- **NCT ID:** NCT03911388
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-12
- **Primary completion:** 2026-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-05-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03911388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03911388, "HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT03911388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*